Clinical Trial Title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of BIIB059 in Adult Participants with Active Systemic Lupus Erythematosus (SLE) Receiving Background Nonbiologic Lupus Standard of CareNational Clinical Trial Number:
NCT04961567Contact Information
Clinical Trial Protocol Description:
This study is being conducted to investigate an experimental drug, BIIB059. The study will determine the effect of the drug in reducing disease activity and inflammation for people with systemic lupus erythematosus (SLE) compared to a placebo group.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are at least 18 years of age.
- Have been diagnosed with SLE at least 24 weeks ago.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.
Study Details
Clinical Trial Investigator
Meenakshi Jolly, MD, MS
Contact Information
Joshlean Fair
Clinical Trial Location
RUSH University Medical Center